Mild swelling can be a temporary reaction after a stem cell injection, especially into a knee joint. But swelling alone cannot tell you whether recovery is going well. A review of 48 knee-osteoarthritis studies involving 1,924 patients reported a 12.3% rate of temporary adverse events—roughly 1 in 8—with swelling and injection-site pain the most frequent. That is not a swelling-only rate. 39564419
Severe or worsening joint pain, redness, or fever needs prompt medical assessment rather than reassurance that it is a “normal reaction.” 000430.htm Trouble breathing or swelling of the face or tongue can signal a life-threatening allergic reaction: call the local emergency number immediately. 000844.htm

How Common Is Swelling?
The 12.3% figure includes temporary adverse events across different knee treatments, not just swelling after one standardized product. Some studies combined injections with surgery, platelet-rich plasma, or hyaluronic acid, which makes the reaction harder to attribute to the cells alone. 39564419
A separate 2026 review of 28 randomized trials found more injection-site pain with intra-articular mesenchymal stem/stromal cell (MSC) treatment than with control injections, with a risk ratio of 2.04. Joint swelling had a risk ratio of 3.39. Serious complications, such as infection, were uncommon, with no statistically significant increase detected; that does not establish equal safety or rule out rare harms. 41863718
Those ratios mean about twice the risk of injection-site pain and over three times the risk of swelling relative to the comparison groups. They do not mean that 3.39% of patients developed swelling. Both reviews concern knee osteoarthritis; their estimates should not be applied to IV infusions, facial injections, or injections into other body sites. 39564419 41863718
How Long Can Swelling Last?
The 48-study review describes local pain and swelling as generally lasting less than four weeks. Its discussion says most temporary events resolved within a week, but it also records some pain or swelling lasting longer than four weeks. Many included studies did not report the timing or duration clearly. There is no single recovery timetable for every product and procedure. 39564419
Four weeks is a description of study findings, not a safe waiting period. Ask your treating clinician what course they expect for your injection and when they want to hear from you. Contact them if swelling is worsening, is not settling as expected, returns after improving, or leaves you unsure what to do. Do not wait for a scheduled follow-up if you develop the warning signs below.
When Should You Seek Medical Help?
Use the symptoms to decide how urgently to act—not the number of days since treatment. This table is a guide to seeking care, not a way to diagnose the cause of swelling.
| What you notice | What to do | Why it matters |
|---|---|---|
| Face or tongue swelling, trouble breathing, difficulty swallowing, or fainting, particularly with hives | Call the local emergency number immediately. | These can be signs of anaphylaxis, which needs emergency treatment. 000844.htm |
| A swollen, red joint with severe pain, fever, or difficulty moving it | Seek urgent medical assessment now; do not wait for routine aftercare. | A joint infection can cause permanent damage if treatment is delayed. 000430.htm |
| New pain, swelling, warmth, or redness in one calf or leg | Seek prompt medical assessment. If chest pain, difficulty breathing, or fainting occurs, call the local emergency number. | A deep vein clot can cause leg symptoms and can travel to the lungs. These are general clot warnings, not a claim that clots are a typical reaction to a knee injection. 000156.htm |
Who Needs Extra Caution?
People with an artificial joint, diabetes, reduced immune defenses, or recent joint surgery have risk factors for septic arthritis. Tell the clinician assessing your swelling about these conditions. A clinician may need to examine the joint and take joint fluid for testing; appearance alone cannot establish the diagnosis. 000430.htm
Why Does the Injected Product Matter?
“Stem cell injection” is not one treatment. Knee studies have used bone marrow aspirate concentrate, bone marrow-derived cells, fat-derived cell preparations, stromal vascular fraction, and culture-expanded MSCs. Their preparation methods and treatment protocols differ. 39564419 Ask whether the cells are your own or from a donor; the distinction between autologous and allogeneic cell sources is one part of identifying what you received.
The FDA lists reactions at collection and administration sites, unwanted inflammatory or immune responses, and bacterial infections among concerns with unapproved regenerative products. Local irritation is therefore one possible explanation for swelling, but it is not a diagnosis you can make from the symptom alone. Important patient and consumer information about regenerative medicine therapies
In its U.S. consumer guidance, the FDA states that the regenerative medicine therapies it describes have not been approved for orthopedic conditions such as osteoarthritis or knee pain. A clinic offering a service is not the same as a product having approval for your condition. Exosome products are also marketed in this area, but exosomes are not stem cells; do not assume that evidence for a cell injection applies to them. Important patient and consumer information about regenerative medicine therapies
What Can You Do at Home?
Follow the written aftercare plan for the procedure you actually had. Ask the treating team to confirm:
- how to care for the injection site and dressing;
- whether cold packs or elevation are appropriate for you;
- how much weight you can put on the joint and which activities to limit;
- which pain medicines you may take and what to do about your usual medicines;
- when your next assessment is and whom to call outside office hours.
Do not use a general article to set your own weight-bearing restrictions or change prescribed medicines, including blood thinners. If you were not given instructions, ask for them rather than copying an aftercare schedule for a different treatment. Home care is not a substitute for assessment of a painful, red, swollen joint. 000430.htm
What to Record Before Calling
Keep the treatment paperwork handy. Write down the injection date, product name if known, treated site, when swelling started, whether it is changing, your measured temperature if available, and how movement has changed. A photo taken from the same angle can help you describe the change, but it cannot rule out infection.
A useful message is: “I had [product or procedure] in [site] on [date]. Swelling began [time] and has [improved, stayed the same, or worsened]. My temperature is [measured value, or not measured]. I can now [describe movement]. I also have [other symptoms]. Where should I be assessed?”
Fill in only what you actually know. If you have emergency symptoms, seek help immediately rather than spending time taking photos or waiting for an online reply.
Does Swelling Mean the Treatment Worked?
No. These reviews do not establish swelling as a marker that cells have “settled in,” repaired cartilage, or produced a useful treatment effect. The 28-trial review found improvements in some pain and function outcomes, but no consistent structural benefit on its MRI-based measure. More local reactions were reported alongside those mixed benefits. 39564419 41863718
Likewise, no swelling does not establish treatment failure. Agree on follow-up measures with your clinician—such as walking pain, stairs, sleep, and medicine use—instead of judging success by how swollen the joint looks.
What Are the Evidence Limits?
The 48-study review searched publications from January 2000 through June 2021. It included mixed study designs, different cell preparations, and treatments with and without other procedures. Adverse-event reporting varied, and the authors could not draw reliable statistical conclusions about relative event rates between product groups. The subgroup percentages should not be used as a head-to-head safety ranking. 39564419
The 2026 review searched through December 10, 2025. Its 28 randomized trials also differed in preparation, cell source, comparison treatment, and follow-up. The reported relative risks are group estimates, not a prediction for one patient or a private clinic’s preparation. 41863718
No serious complications were reported in the studies included in the 48-study review, but the authors called for better reporting and longer-term evidence. That finding does not mean the risk is zero. 39564419 The FDA has received reports of serious harm with unapproved regenerative products, including infections, blindness, and tumor formation. These reports describe possible harms, not their frequency in knee trials. Important patient and consumer information about regenerative medicine therapies
Does Approval in Japan Change the Advice?
No regulatory label makes new symptoms automatically harmless. In Japan, providers offering regenerative medicine under the safety law must complete the required procedures, including treatment-plan submission and reporting. A filed regenerative medicine treatment plan is not proof that a treatment has demonstrated efficacy or that a product has marketing approval for your disease. Index
PMDA’s approved-product list identifies specific products and uses. For example, it lists Savyscus Injection, approved in May 2026 for a specified meniscal-injury setting involving arthroscopic repair—not a blanket approval for injections for knee pain. Ask for the exact product and indication rather than relying on the phrase “approved in Japan.” 000283257.pdf
Ask separately about product approval, any clinical-study oversight, and the clinic’s safety-law treatment plan. These describe different regulatory arrangements and may overlap; none replaces a clear plan for assessing swelling after you return home.
What Should You Ask the Clinic?
- What exactly was injected—cell source, preparation, dose, and any other substances?
- What approval or study framework applies to this product and my condition?
- What swelling is expected with this exact procedure, and when should I contact you?
- How will you assess swelling that is worsening or not settling?
- What infections or other complications have you recorded, over what period, and among how many patients?
- Who answers after hours, and what number do I call?
- Which symptoms mean emergency care instead of waiting for your reply?
- What follow-up is included, and who will examine me if needed?
- If I travel home, who takes over my follow-up?
Planning a consultation in Japan? Bring the nine questions above.
Use the contact form for non-urgent consultation questions. For new or worsening symptoms, seek medical care rather than waiting for an online reply.
Bottom Line
Mild swelling can be temporary, but “normal” cannot be decided from swelling alone. The often-quoted 12.3% figure—roughly 1 in 8—covers temporary adverse events in knee-osteoarthritis studies, not swelling alone or every type of stem cell injection. Four weeks is not a safe waiting rule. 39564419 Seek prompt assessment for severe joint pain, redness, or fever, and emergency help for breathing trouble or face or tongue swelling. 000430.htm 000844.htm
This article provides general information, not a diagnosis or an individual aftercare plan.




